Pneumonitis

Search with Google Search with Bing
Information
Disease name
Pneumonitis
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04590547 Active, not recruiting Phase 2 GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) May 7, 2021 December 2023
NCT00997555 Completed N/A Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients October 2009 July 2012
NCT02246361 Completed Phase 4 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication September 2014 May 2015
NCT02788643 Completed Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies May 2014 December 2017
NCT03012958 Completed Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease July 2014 May 2018
NCT03730428 Completed Everolimus Related Pneumonitis in MBC July 15, 2017 June 15, 2020
NCT00081315 Completed Phase 2 Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer November 2003 August 2006
NCT04721444 Completed Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) January 27, 2021 March 1, 2022
NCT04302688 Completed Accurate Classification System for Patients With COVID-19 Pneumonitis December 10, 2019 March 4, 2020
NCT05455034 Recruiting Phase 1/Phase 2 Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis August 1, 2023 June 30, 2025
NCT05280873 Recruiting Phase 1 Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP October 10, 2021 October 20, 2024
NCT04040244 Terminated N/A Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis December 9, 2019 March 10, 2022
NCT03962725 Terminated Phase 4 Avoiding Neuromuscular Blockers to Reduce Complications August 7, 2019 December 19, 2022
NCT04370834 Terminated Phase 2 Tocilizumab for Patients With Cancer and COVID-19 Disease May 28, 2020 January 14, 2021
NCT04326725 Unknown status Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia March 20, 2020 September 1, 2020